West Pharmaceutical Services Inc
WST· NYSE
Released Jul 27, 2017, before the open
10-Q filed Aug 1, 2017, 32 days after period end · 0000105770-17-000042
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Revenue | $397.60M | $388.00M | $359.70M | $368.90M |
| Net Income | $38.80M | $44.70M | $27.80M | $37.60M |
| EPS Diluted |
West Pharmaceutical Services Inc · CIK 105770 · Engraved from SEC EDGAR
| $0.51 |
| $0.60 |
| $0.38 |
| $0.52 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.